Gastroretentive microballoons of metformin: Formulation development and characterization

Journal of Advanced Pharmaceutical Technology and Research

Volumn 2, Issue 1, 2011, Pages 51-55

  Yadav, Akash ^a   Jain, Dinesh Kumar ^a  

^a IPS Academy   (India)

Author keywords

Ethyl cellulose; floating microballoons; hydroxypropylmethyl cellulose; in vitro release; metformin

Indexed keywords

METFORMIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RETENTION; DRUG SOLUBILITY; IN VITRO STUDY; MEAN RESIDENCE TIME; MICROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLVENT EFFECT;

EID: 79955751094     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.79806     Document Type: Article

References (27)

1. Seth PR, Tossounian J. The hydrodynamically balanced system HBS TM: A novel drug delivery system for oral use, Drug Dev Ind Pharm 1984;10:313-39. (Pubitemid 14137879)
2. Moes AJ, Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10:143-95. (Pubitemid 23198886)
3. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlledrelease drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 1996;22:531-9. (Pubitemid 26197851)
4. Whitehead L, Fell JT, CollettJH, Sharma HL, Smith A. Floating dosage forms: An in vivostudy demonstrating prolonged gastric retention. J Control Release 1998;55:3-12. (Pubitemid 28477559)
5. Talukder R, Fassihi R. Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm 2004;30:1019-28. (Pubitemid 39577994)
6. Rouge N, Leroux JC, Cole ET, Doelker E, Buri P. Prevention of the sticking tendency of floating minitablets fi lled into hard gelatin capsules. Eur J Pharm Biopharm 1997;43:165-71. (Pubitemid 28298797)
7. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vivo evaluation of riboflavin containingmicroballoons for floating controlled drug delivery system in healthy human volunteers. J Control Release 2003;93:39-47. (Pubitemid 37346267)
8. Kawashima Y, Niwa T, Takechi H, Hino T, Itoh Y. Hollow microballoons for use as floating controlled drug delivery systems in the stomach. J Pharm Sci 1992;81:135-40.
9. Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Microballoons as floating drug delivery systems to increase gastric retention of drugs. Drug Metab Rev 2002;33:49-160.
10. Muthusamy K, Govindarazan G, Ravi TK. Preparation and evaluation of lansoprazole floating micropellets. Ind J Pharm Sci 2005;67:75-9.
11. Thanoo BC, Sunny MC, Jayakrishnan A. Oral sustained-release drug delivery systems using polycarbonate microballoons capable of floating on the gastric fluid. J Pharm Pharmacol 1993;45:21-4. (Pubitemid 23036475)
12. Joseph NJ, Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microballoons: In vitro and in vivo evaluation in rabbits. J Control Release 2002;79:71-9. (Pubitemid 34164162)
13. Stithit S, Chen W, Price JC. Development and characterization of buoyant theophylline microballoons with near zero order release kinetics. J Microencapsul 1998;15:725-37. (Pubitemid 28490943)
14. Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microballoons. J Microencaps 1999; 16:715-29. (Pubitemid 29478951)
15. Yadav A, Jain DK. In vitro characterization of gastroretentive microballoons prepared by the emulsion solvent diffusion method. J Adv Pharm Tech Res 2010;1:56-67.
16. Struebel A, Siepmann J, Bodmeier R. Multiple units gastroretentive drug delivery systems: A new preparation method for low density microballoons. J Microencapsul 2003;20:329-47. (Pubitemid 36621475)
17. The Indian Pharmacopoeia, Vol-II, Indian Pharmacopoeia Commission, Ghaziabad, 2007. p. 740-42.
18. Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235-59.
19. Dinarvand R, Mirfattahi S, Atyabi F. Preparation characterization and in vitro drug release of isosorbide dinitrate microballoons. J Microencapsul 2002;19:73-81. (Pubitemid 34083463)
20. Abrol S, Trehan A, Katare OP. Formulation, characterization, and in vitro evaluation of silymarin-loaded lipid microballoons. Drug Deliv 2004;11:185-91. (Pubitemid 38720415)
21. Reddy BP, Dorle AK, Krishna DK. Albumin microballoons: Eff ect of process variables on the distribution and in vitro release. Drug Dev Ind Pharm 1990;16:1781-803.
22. Ishizaka T. Preparation of egg albumin microballoons and microcapsules. J Pharm Sci1981;70:358-61.
23. Ratcliffe JH, Hunney Ball IM, Wilson CG, Smith A, Davis SS. Albumin microballoons for intra articular drug delivery: Investigation of their retention in normal and arthritic knee joints of rabbits. J Pharm Pharmacol 1987;39:290-5. (Pubitemid 17046856)
24. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profi les. Eur J Pharm Sci 1987;39:39-45.
25. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-7.
26. Schefter E, Higuchi T. Dissolution behavior of crystalline solvated and non-solvated forms of some pharmaceuticals. J Pharm Sci 1963;52:781-91.
27. Yadav A, Jain DK. Formulation and characterization of gastroretentive floating microballoons of metformin. Int J Pharm Sci Res 2010;1:38-43.